These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2913992)

  • 1. Predicting survival in bilateral breast carcinoma.
    Alexander AI; Mercer RJ; Muir IM; Mason B; Holdaway I
    Aust N Z J Surg; 1989 Jan; 59(1):35-7. PubMed ID: 2913992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
    Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
    Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
    Howat JM; Harris M; Swindell R; Barnes DM
    Br J Cancer; 1985 Feb; 51(2):263-70. PubMed ID: 3966982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term study of the significance of hormone receptors as prognostic factors in breast cancer].
    Merkle E; Seidl I; Bähr I; Tulusan AH; von Maillot K; Sauerbrei KW; Wirtz PM
    Geburtshilfe Frauenheilkd; 1990 Jul; 50(7):528-32. PubMed ID: 2391019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Androgen receptors in primary breast carcinoma. Relation to prognostic factors in comparison with estrogen and progesterone receptors].
    Reiner G; Jakesz R; Kolb R; Kühnl-Brady K; Reiner A; Schemper M; Spona J
    Dtsch Med Wochenschr; 1988 Jun; 113(22):892-7. PubMed ID: 3371221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relation of steroid hormone receptors to axillary lymph node metastasis in breast carcinoma].
    Etzrodt A; Jung H; Schweissfurth C; Tolxdorff T; Lamberti G
    Geburtshilfe Frauenheilkd; 1983 Dec; 43(12):726-31. PubMed ID: 6559147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Season of tumour detection influences factors predicting survival of patients with breast cancer.
    Mason BH; Holdaway IM; Stewart AW; Neave LM; Kay RG
    Breast Cancer Res Treat; 1990 Jan; 15(1):27-37. PubMed ID: 2328328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and oestrogen receptors in human breast cancer.
    Holdaway IM; Mountjoy KG
    Aust N Z J Med; 1978 Dec; 8(6):630-8. PubMed ID: 285684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormone receptor status and mitotic activity as risk factors for recurrence and death in female breast carcinoma.
    Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
    Anticancer Res; 1991; 11(5):1701-6. PubMed ID: 1768039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone receptors as a prognostic factor in Stage II breast cancer.
    Clark GM; McGuire WL; Hubay CA; Pearson OH; Marshall JS
    N Engl J Med; 1983 Dec; 309(22):1343-7. PubMed ID: 6633596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Steroid receptors--their meaning in the treatment of breast neoplasms].
    Aiginger P
    Acta Med Austriaca; 1978; 5(4-5):156-8. PubMed ID: 756130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Steroid hormone receptors and survival in breast cancer patients].
    Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
    Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting recurrence and survival in breast cancer. A panel discussion.
    McGuire WL; Clark GM; Fisher ER; Henderson IC
    Breast Cancer Res Treat; 1987; 9(1):27-38. PubMed ID: 3593989
    [No Abstract]   [Full Text] [Related]  

  • 14. Estrogen and progesterone receptor content in bilateral breast cancer.
    Branković-Magić M; Nikolić-Vukosavljević D; Nesković-Konstantinović Z; Kanjer K; Spuzić I
    Pathol Res Pract; 1995 Feb; 191(1):16-24. PubMed ID: 7651928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
    Ba JL; Liu CG; Jin F
    Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone and estrogen receptors as prognostic variables in breast cancer.
    Mason BH; Holdaway IM; Mullins PR; Yee LH; Kay RG
    Cancer Res; 1983 Jun; 43(6):2985-90. PubMed ID: 6850609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid-hormone receptors and survival after first relapse in breast cancer.
    Howell A; Barnes DM; Harland RN; Redford J; Bramwell VH; Wilkinson MJ; Swindell R; Crowther D; Sellwood RA
    Lancet; 1984 Mar; 1(8377):588-91. PubMed ID: 6142305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer.
    Hawkins RA; White G; Bundred NJ; Dixon JM; Miller WR; Stewart HJ; Forrest AP
    Br J Surg; 1987 Nov; 74(11):1009-13. PubMed ID: 3690224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S-phase fraction and nuclear size in long term prognosis of patients with breast cancer.
    Meyer JS; Province MA
    Cancer; 1994 Oct; 74(8):2287-99. PubMed ID: 7922981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a prognostic index in breast cancer.
    Alexander AI; Mercer RJ; Muir IM; Bennett RC; Rennie GC
    Aust N Z J Surg; 1987 Jun; 57(6):399-403. PubMed ID: 3675395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.